Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia

NCT01507727 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-hypovolemic Non-acute Hyponatremia

Interventions

DRUG: Tolvaptan
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]